Vertex Solutions, a small business known for the manufacturing of systems integration and advanced training technologies, has ...

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...

Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...

Vertex Securities Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Certificate under Regulation 74 (5) of the Securities Exchange Board of India (Depositories and ...

Vertex' therapy takes the form of stem cell-derived human pancreatic islet cells, which secrete insulin in the body in response to rising blood glucose. The aim is to replace the pancreatic tissue ...

Zacks Research has upped the financial bar for Vertex Pharmaceuticals, boosting its 2026 earnings forecast from $16.18 to $16 ...